Business updates
Breaking life sciences news in Boston
video
Community
Discussions
- What Beatles songs do you want in Rock Band?
- The future of the US auto industry
- Good things to come out of the recession?
- What out-of-business store do you miss the most?
- Have a tax question? Ask a CPA
Inside business
Healthcare and fitness updates from the Boston Globe.
Today's Globe: doctors via robots, chelation study, swine flu in Britain
The robot glides past the beeping heart monitor, past a row of patients supine on their electric beds, past the beehive of the nurses’ station....
Globe Columnist
Judy Foreman
Health Sense
Local resources
Markets
Track life sciences stocks
Find news, charts, and prices for publicly traded life sciences companies.
Jobs
Making a change?
Check out career opportunities in health and biotechnology in Greater Boston.
Mobile machines, remote hookups help Lahey Clinic cope with shortage of specialists
BEVERLY - The robot glides past the beeping heart monitor, past a row of patients supine on their electric beds, past the beehive of the nurses’ station. The sleek, metallic body, dusky blue, stops outside Room 9 and slowly rolls through the doorway. (By Kathleen Burge, Globe Staff)
Drug firms' suit against MIT unusual
Biotech companies fight with each other over the commercial rights to ideas and technology all the time. Patent lawsuits are as much a part of the business as lab work and clinical trials. (By Steven Syre, Globe Columnist)
Sanofi-Aventis heart drug approved
NEW YORK - Sanofi- Aventis SA said its drug Multaq, which treats irregular heart rhythms, received marketing approval after a delay of nearly three years. (By Associated Press, Boston Globe)
J&J to buy $1b stake in drug maker Elan
LONDON - Johnson & Johnson agreed to pay $1 billion for a stake in Elan Corp. and will develop the Irish drug maker’s medicines against Alzheimer’s disease. (By Shannon Pettypiece and Trista Kelley, Bloomberg News)
Early Glance: Medical Devices companies
Shares of some top medical devices companies are down at 10 a.m.: Abbott Labs fell $.42 or .9 percent, to $46.22. (AP)
Discovery Laboratories shares dive on FDA delay
Shares of Discovery Laboratories Inc. fell to their lowest point in a decade Thursday after the company said a Food and Drug Administration review standard places the approval of Surfaxin in doubt. (AP)
Scrub tech may have exposed thousands to hepatitis
A former surgery technician may have exposed thousands of Colorado patients to hepatitis C when she swapped her own dirty syringes for ones filled with a powerful narcotic, federal authorities said Thursday. (AP)
Boston Globe
- Study: More bladder cancer care is no help (By Maggie Fox, Reuters)
- In double transplant, left hand works first (By Randolph E. Schmid, Associated Press)
- Tracing mutation's Colonial roots reveals much about cancer strain (By Stephen Smith, Globe Staff)
- Recession dims chances for small medical firms (By Barnaby J. Feder, New York Times)
- THE GREEN BLOG Woods Hole research centers join forces (By Beth Daley, Globe Staff)
More headlines
- Graceway buys 3 Pfizer skin drug candidates (AP, 7/2/09)
- Early Glance: Managed Care companies (AP, 7/2/09)
- Early Glance: PBM companies (AP, 7/2/09)
- Early Glance: Pharmaceuticals companies (AP, 7/2/09)
- Final Glance: Health Care Equipment companies (AP, 7/2/09)
- Genentech says Lucentis met goal in clinical trial (AP, 7/2/09)
- Final Glance: Managed Care companies (AP, 7/2/09)
- Final Glance: PBM companies (AP, 7/2/09)
- Final Glance: Medical Devices companies (AP, 7/2/09)
- Final Glance: Biotechnology companies (AP, 7/2/09)